Magic mushrooms take on OCD: new trial tests doses for relief

NCT ID NCT07347405

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether psilocybin, the active ingredient in magic mushrooms, can safely help people with obsessive-compulsive disorder (OCD). Thirty adults with moderate to severe OCD who haven't improved with standard treatments will receive either a low, medium, or high dose of whole mushroom in chocolate. The goal is to see if it reduces OCD symptoms and improves quality of life over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE - COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obsessive-compulsive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Clinical and Translational Sciences Research Center

    RECRUITING

    Tucson, Arizona, 85724, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••